Torrent Pharma Q2 Profit Soars 17.3%, Revenue Grows 8.6%

28 Oct 2024 , 12:16 PM

Torrent Pharmaceuticals released its Q2 financial results on October 25, 2024, highlighting an 8.61% year-on-year increase in topline revenue and a 17.36% rise in net profit compared to the same quarter last year.

At the time of writing on October 28, 2024 at 12:12 pm, shares of Torrent Pharmaceuticals is trading at ₹3332.90 which is a 2.91% dip than the previous close. Torrent Pharmaceutical has gained a total of 72% in the last one year, and 45% since the beginning of the year.

When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.

The company effectively managed its Selling, General & Administrative (SG&A) expenses, which decreased by 1.27% from the prior quarter but increased by 7.95% year-on-year, reflecting ongoing cost management initiatives.

Operating income improved by 4.81% compared to the previous quarter and saw a notable 18.75% increase year-on-year, demonstrating enhanced operational efficiency.

The earnings per share (EPS) for Q2 reached ₹13.37, representing a year-on-year growth of 17.38%, which positively impacts shareholder value.

Overall, Torrent Pharmaceuticals’ performance in Q2 showcases resilience and growth, driven by effective cost management and operational improvements, reinforcing its position in the pharmaceutical market.